focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.025
Bid: 1.00
Ask: 1.05
Change: 0.00 (0.00%)
Spread: 0.05 (5.00%)
Open: 1.025
High: 1.025
Low: 1.025
Prev. Close: 1.025
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

4 Feb 2021 10:22

RNS Number : 0131O
Microsaic Systems plc
04 February 2021
 

4 February 2021

Microsaic Systems plc

("Microsaic" or the "Company")

Result of General Meeting and Total Voting Rights

Microsaic Systems plc (AIM: MSYS), the point-of-need mass spectrometry company, is pleased to announce that, at its General Meeting held earlier today in connection with the fundraise, the share reorganisation and the proposed Board changes announced on 19 January 2021, all Resolutions were put to a meeting on a poll and were duly passed. The voting results from the General Meeting are included at the foot of this announcement.

Application has been made to the London Stock Exchange for 5,620,000,000 new ordinary shares of 0.01 pence each ("Ordinary Shares"), which comprise the Placing Shares, the Fees Shares and the Broker Option Shares, to be admitted to trading on AIM. It is expected that Admission will occur and dealings will commence on 5 February 2021 at 8.00 a.m.

Total voting rights

Following Admission, the Company will have 6,076,365,146 Ordinary Shares in issue. The Company holds no shares in treasury. Therefore, the Company hereby confirms that the total number of voting rights in the Company will, following Admission, be 6,076,365,146.

Shareholders may use this figure of 6,076,365,146 as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Rules and Transparency Rules.

A separate announcement will be made tomorrow relating to the planned Board changes which will become effective immediately following Admission.

 

Defined terms used in this announcement have the meanings (unless the context otherwise requires) set out in the Circular dated 19 January 2021, which is available on the Company's website at https://www.microsaic.com/investors/documents/.

 

Glenn Tracey, CEO of Microsaic, commented:

''We are delighted to have received substantial support from our existing shareholders, and welcome the significant support from new shareholders introduced by Turner Pope. The net proceeds from the Placing are expected to accelerate commercialisation of Microsaic's miniaturised products and services by expanding sales, marketing and distribution channels through collaboration, cooperation and partnerships. Beyond general working capital use, funding will be directed to targeting new revenue streams by exploring out-licensing opportunities of our robust IP portfolio while sharing costs of joint development that may lead to new income from shared products and services."

 

 

Enquiries:

 

 

Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD

+44 (0)1483 751 577

 

N+1 Singer (Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / George Tzimas (Corporate Finance)

 

Tom Salvesen (Corporate Broking)

 

 

Turner Pope Investments (TPI) Limited (Joint Broker)

Zoe Alexander (Corporate Broking)

Andy Thacker (Corporate Broking)

 +44 (0)20 3657 0050

 

 

General Meeting voting results:

 

Resolutions

Votes 

For

% of votes cast

Votes

Against

% of votes cast

Votes

Withheld

1*

To approve the proposed amendments to the Company's existing articles of association, as set out in the Notice of General Meeting.

330,985,981

99.94

210,338

0.06

11,742,973

2

To approve the share reorganisation as set out in the Notice of General Meeting.

340,785,981

99.94

210,338

0.06

1,942,973

3

To grant the Directors authority to allot equity securities in the Company in the amounts set out in the Notice of General Meeting.

340,772,440

99.93

223,879

0.07

1,942,973

4*

To empower the Directors to disapply pre-emption rights on the issue of equity securities in the Company in the amounts set out in the Notice of General Meeting.

340,780,981

99.94

215,338

0.06

1,942,973

5

To appoint Gerard Brandon as a Director of the Company.

342,585,981

99.94

210,338

0.06

142,973

6

To appoint Nigel Burton as a Director of the Company.

342,585,981

99.94

210,338

0.06

142,973

*Special Resolution

 

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company which develops point-of-need mass spectrometers (MS) designed to improve the efficiency of chemical and biological workflows.

The Company was initially established to develop miniaturised MS instruments based on micro-electromechanical systems (MEMS) technology originating at the highly regarded Optical and Semiconductor Devices Group at Imperial College London. Since being established in 2001, the Company has invested substantially in core intellectual property specific to its miniaturised MS, with over 60 patents in chip based, compact MS.

 

The Company has sold over 160 instruments to date and has signed over ten commercial partners, including in North America, Europe, China, SE Asia and Japan, with the majority of signings occurring in 2018 and 2019. For more information, please go to www.microsaic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMDKQBBKBKDKBK
Date   Source Headline
5th Mar 20197:00 amRNSInvestor Event
19th Feb 20197:00 amRNSNotice of Results
11th Jan 20197:00 amRNSNew Protein Identification Product
19th Dec 201811:20 amRNSBioprocessing partnership update & trading update
7th Nov 20187:00 amRNSExclusive US and Canada Distribution Agreement
3rd Sep 20187:00 amRNSInterim Results
7th Aug 20187:00 amRNSNotice of Results
29th Jun 20184:12 pmRNSHolding(s) in Company
26th Jun 20182:04 pmRNSHolding(s) in Company
25th Jun 201810:10 amRNSDirectors' Interests
22nd Jun 201810:40 amRNSResult of GM, Completion of Fundraising & TVR
21st Jun 20187:00 amRNSDistribution Agreement with Amedis, spol. s ro.
13th Jun 20187:00 amRNSDistribution Agreement with Omicron Research Ltd.
6th Jun 20187:00 amRNSSuccessful Fundraising of £5.5 million
5th Jun 20184:46 pmRNSPrimaryBid.com Offer
5th Jun 20184:45 pmRNSFundraising
24th May 20187:00 amRNSDistribution Agreement with Stable Arm Sdn. Bhd.
9th May 20187:00 amRNSAgreement with Rightek Co., Ltd.
4th May 201811:25 amRNSResult of AGM
4th May 20187:00 amRNSAGM Statement
12th Apr 20187:00 amRNSMicrosaic signs Agreement with Knauer
6th Apr 20187:00 amRNSNotice of AGM and Posting of Annual Report
28th Mar 20187:00 amRNSAgreement with Unimicro Technologies Inc.
23rd Mar 20184:45 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSCommercial contract with CPI Innovation Services
5th Mar 20187:00 amRNSFinal Results
21st Feb 20187:00 amRNSNotice of Results
3rd Jan 20187:00 amRNSAward of Options
19th Dec 20177:00 amRNSDirectorate Change
13th Dec 20177:00 amRNSResearch agreement with global biopharma partner
28th Sep 20177:00 amRNSInterim Results
25th Sep 20177:00 amRNSAppointment of CEO
13th Sep 20177:00 amRNSMicrosaic to Exhibit at BioProcess International
14th Aug 20177:00 amRNSNotice of Results
19th Jun 20177:00 amRNSTrading Statement
15th May 201711:42 amRNSResult of AGM
11th May 20177:00 amRNSMicrosaic Enhances Bioprocessing Capabilities
26th Apr 20177:00 amRNSIntegration with SCPA chromatography software
21st Apr 20177:00 amRNSNotice of AGM
7th Apr 20177:00 amRNSAgreement
21st Mar 20177:00 amRNSFinal Results
13th Mar 20177:00 amRNSChange of registrar
24th Jan 201712:56 pmRNSAppointment of Interim Chairman
13th Dec 20167:00 amRNSTrading Statement
28th Sep 20167:00 amRNSDirectorate Change
21st Sep 20164:39 pmRNSHolding(s) in Company
16th Sep 20161:44 pmRNSDirector/PDMR Shareholding
15th Sep 20161:03 pmRNSHolding(s) in Company
15th Sep 201610:02 amRNSTR-1: Notification of Major Interest in Shares
14th Sep 20165:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.